NasdaqGM:HRMYPharmaceuticals
Will Harmony’s New COO and Board Reboot Change Harmony Biosciences Holdings' (HRMY) Narrative?
Harmony Biosciences Holdings, Inc. recently appointed former director Peter Anastasiou as Chief Operating Officer and reshaped its Board by adding finance-focused executive Troy Ignelzi and nominating industry veteran Geno J. Germano for election at the 2026 Annual Meeting of Shareholders.
This leadership reshuffle brings together deep commercial, operational, and capital markets experience, potentially influencing how Harmony executes on its rare neurological disease portfolio and...